Uncovering the molecular subtypes of triple-negative breast cancer with a noninvasive radiomic methodology

por Su, Guan-Hua, Xiao, Yi, Jiang, Yi-Zhou, Shao, Zhi-Ming
Publicado 2022

Prediction of clinicopathological features, multi-omics events and prognosis based on digital pathology and deep learning in HR(+)/HER2(−) breast cancer

por Hu, Jia, Lv, Hong, Zhao, Shen, Lin, Cai-Jin, Su, Guan-Hua, Shao, Zhi-Ming
Publicado 2023

Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence

por Xu, Ying, Su, Guan-Hua, Ma, Ding, Xiao, Yi, Shao, Zhi-Ming, Jiang, Yi-Zhou
Publicado 2021

Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer

por Su, Guan-Hua, Xiao, Yi, Jiang, Lin, Zheng, Ren-Cheng, Wang, He, Chen, Yan, Gu, Ya-Jia, You, Chao, Shao, Zhi-Ming
Publicado 2022

Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer

por Jiang, Lin, You, Chao, Xiao, Yi, Wang, He, Su, Guan-Hua, Xia, Bing-Qing, Zheng, Ren-Cheng, Zhang, Dan-Dan, Jiang, Yi-Zhou, Gu, Ya-Jia, Shao, Zhi-Ming
Publicado 2022

Novel Antibody against a Glutamic Acid-Rich Human Fibrinogen-Like Protein 2-Derived Peptide near Ser91 Inhibits hfgl2 Prothrombinase Activity

por Li, Wen-Zhu, Wang, Jue, Long, Rui, Su, Guan-Hua, Bukhory, Dinesh-Kumar, Dai, Jing, Jin, Nan, Huang, Shi-Yuan, Jia, Peng, Li, Ting, Fan, Chen, Liu, Kun, Wang, Zhaohui
Publicado 2014

Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets

por Su, Guan-Hua, Xiao, Yi, You, Chao, Zheng, Ren-Cheng, Zhao, Shen, Sun, Shi-Yun, Zhou, Jia-Yin, Lin, Lu-Yi, Wang, He, Shao, Zhi-Ming, Gu, Ya-Jia, Jiang, Yi-Zhou
Publicado 2023